Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

mRNA-1273 Vaccine Efficacy against the Delta Variant Participants who had received placebo in a previous phase of this trial were offered the mRNA-1273 vaccine in the open-label phase. The incidenc...

Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | Litlas